Four new therapies offer hope to patients with congestive heart failure.  New medications in various stages of development may provide alternatives to current drugs that relax arteries and reduce fluid retention.
D001826:Body Fluids; D001834:Body Water; D005440:Fluid Therapy; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D058915:Purinergic P1 Receptor Antagonists; D014462:Ultrafiltration; D014665:Vasodilator Agents; D014667:Vasopressins / Q000037:antagonists & inhibitors
D058915:Purinergic P1 Receptor Antagonists; D014665:Vasodilator Agents; D014667:Vasopressins